Editorial Plastic Surgery
Association between high-flow nasal oxygen and in-hospital mortality: evidence from rural primary-care patients

Association between high-flow nasal oxygen and in-hospital mortality: evidence from rural primary-care patients

Authors

Zainab Ahmed

Zainab Ahmed

Karolinska University Hospital, Mongolia

Noura Nasser

Noura Nasser

Toronto General Hospital, South Georgia

Aisha Silva

Aisha Silva

Royal Melbourne Hospital, Burkina Faso

Freya Herrera

Freya Herrera

Charité Berlin, Bonaire, Sint Eustatius and Saba

Corresponding
Leo Dubois

Leo Dubois

Cleveland Clinic Abu Dhabi, Oman

Published

October 17, 2023

Paper ID

PAP-000232

Status

Published

DOI

10.65712/tmj.test000490

Association between high-flow nasal oxygen and in-hospital mortality: evidence from rural primary-care patients

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of high-flow nasal oxygen were small or single-centre. Methods: We conducted a quality-improvement audit across 11 centres between 2018 and 2023. Results: Serious adverse events were rare and similar between groups. Serious adverse events were rare and similar between groups. Conclusion: Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.

References

1. Moreau H, Osei K, et al. Early mobilisation and medication adherence. Eur Heart J. 2019;393(5):652-1337.

2. Nasser S, Kim S, et al. Early enteral nutrition and health-related quality of life. JAMA. 2019;170(1):895-1596.

3. Farouk G, Volkov V, et al. An antibiotic stewardship programme and in-hospital mortality. BMC Med. 2013;271(7):417-1020.

4. Mensah E, Zhang Y, et al. High-flow nasal oxygen and emergency department revisits. JAMA. 2024;280(6):780-908.

5. Kaur F, Rossi Z, et al. Delayed cord clamping and ventilator-free days. JAMA. 2022;184(4):713-1311.

Introduction

Earlier studies of high-flow nasal oxygen were small or single-centre. The cost of in-hospital mortality to health systems is substantial. Guidelines make only a weak recommendation on high-flow nasal oxygen. in-hospital mortality remains a leading cause of avoidable harm among rural primary-care patients.

Guidelines make only a weak recommendation on high-flow nasal oxygen. The cost of in-hospital mortality to health systems is substantial.

Earlier studies of high-flow nasal oxygen were small or single-centre. The cost of in-hospital mortality to health systems is substantial.

in-hospital mortality remains a leading cause of avoidable harm among rural primary-care patients. Practice around high-flow nasal oxygen varies widely between centres.

Materials and Methods

The primary outcome was in-hospital mortality, assessed blind to allocation. Eligible participants were rural primary-care patients. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

Missing data were handled with multiple imputation. The primary outcome was in-hospital mortality, assessed blind to allocation.

The primary outcome was in-hospital mortality, assessed blind to allocation. Eligible participants were rural primary-care patients.

Results

2751 participants were included (median age 42 years). The adjusted odds ratio was 0.45 (95% CI 0.34 to 0.75). The adjusted odds ratio was 0.55 (95% CI 0.44 to 0.74). 1645 participants were included (median age 29 years).

GroupnEventsRate %
Age ≥ 654501187.0
Centre A265129.2
Control814433.2
Female663602.7
Control1256037.9
Centre B4294635.0
Age < 656139740.9
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Forest plot of in-hospital mortality
Shown for rural primary-care patients; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Forest plot of in-hospital mortality
Shown for rural primary-care patients; error bars are 95% confidence intervals.

2954 participants were included (median age 79 years). Effects were consistent across prespecified subgroups. 2311 participants were included (median age 63 years).

in-hospital mortality occurred in 22% of the intervention group versus 22% of controls. The adjusted odds ratio was 0.81 (95% CI 0.49 to 0.70).

Discussion

Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. These findings suggest that high-flow nasal oxygen is associated with better in-hospital mortality in rural primary-care patients.

Strengths include the sample size and blinded outcome assessment. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.

Conclusions

High-flow nasal oxygen may be offered for rural primary-care patients to improve in-hospital mortality.

Appendices

Supplementary tables are available on request.